Concourse Financial Group Securities’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-63
| Closed | -$999 | – | 618 |
|
|
2024
Q4 | $999 | Buy |
63
+15
| +31% | +$238 | ﹤0.01% | 2098 |
|
|
2024
Q3 | $1.15K | Sell |
48
-5
| -9% | -$120 | ﹤0.01% | 2045 |
|
|
2024
Q2 | $1.06K | Buy |
53
+35
| +194% | +$697 | ﹤0.01% | 2113 |
|
|
2024
Q1 | $358 | Sell |
18
-40
| -69% | -$796 | ﹤0.01% | 2238 |
|
|
2023
Q4 | $1.3K | Buy |
58
+10
| +21% | +$224 | ﹤0.01% | 2079 |
|
|
2023
Q3 | $970 | Hold |
48
| – | – | ﹤0.01% | 2102 |
|
|
2023
Q2 | $1.23K | Sell |
48
-1
| -2% | -$26 | ﹤0.01% | 2105 |
|
|
2023
Q1 | $1.46K | Hold |
49
| – | – | ﹤0.01% | 2107 |
|
|
2022
Q4 | $1.33K | Buy |
49
+2
| +4% | +$54 | ﹤0.01% | 2110 |
|
|
2022
Q3 | $1K | Buy |
+47
| New | +$1K | ﹤0.01% | 1840 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2555 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | – | – | 2516 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2701 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2718 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2664 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2621 |
|
|
2020
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2568 |
|
|
2020
Q3 | – | Sell |
-225
| Closed | -$7K | – | 2432 |
|
|
2020
Q2 | $7K | Sell |
225
-12
| -5% | -$373 | ﹤0.01% | 1569 |
|
|
2020
Q1 | $6K | Sell |
237
-1
| -0.4% | -$25 | ﹤0.01% | 1581 |
|
|
2019
Q4 | $8K | Buy |
238
+235
| +7,833% | +$7.9K | ﹤0.01% | 1484 |
|
|
2019
Q3 | $0 | Sell |
3
-270
| -99% | – | ﹤0.01% | 2040 |
|
|
2019
Q2 | $12K | Sell |
273
-17
| -6% | -$747 | ﹤0.01% | 1418 |
|
|
2019
Q1 | $12K | Hold |
290
| – | – | ﹤0.01% | 1443 |
|
|
2018
Q4 | $12K | Buy |
290
+288
| +14,400% | +$11.9K | ﹤0.01% | 1342 |
|
|
2018
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1883 |
|